• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1受体与拮抗剂的晶体结构揭示了一种新的细胞因子-受体结合模式。

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.

作者信息

Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett R W

机构信息

Marion Merrell Dow Research Institute, Strasbourg, France.

出版信息

Nature. 1997 Mar 13;386(6621):194-200. doi: 10.1038/386194a0.

DOI:10.1038/386194a0
PMID:9062194
Abstract

Inflammation, regardless of whether it is provoked by infection or by tissue damage, starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines interleukin-1 (IL-1) and tumour necrosis factor-alpha (ref. 1). Three naturally occurring ligands for the IL-1 receptor (IL1R) exist: the agonists IL-1alpha and IL-1beta and the IL-1-receptor antagonist IL1RA (ref. 2). IL-1 is the only cytokine for which a naturally occurring antagonist is known. Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of type-I IL1R complexed with IL1RA. The receptor consists of three immunoglobulin-like domains. Domains 1 and 2 are tightly linked, but domain three is completely separate and connected by a flexible linker. Residues of all three domains contact the antagonist and include the five critical IL1RA residues which were identified by site-directed mutagenesis. A region that is important for biological function in IL-1beta, the 'receptor trigger site' is not in direct contact with the receptor in the IL1RA complex. Modelling studies suggest that this IL-1beta trigger site might induce a movement of domain 3.

摘要

炎症,无论其是由感染还是组织损伤引发,均始于巨噬细胞的激活,巨噬细胞通过产生细胞因子白细胞介素-1(IL-1)和肿瘤坏死因子-α引发一系列炎症反应(参考文献1)。白细胞介素-1受体(IL1R)有三种天然存在的配体:激动剂IL-1α和IL-1β以及白细胞介素-1受体拮抗剂IL1RA(参考文献2)。IL-1是唯一已知存在天然拮抗剂的细胞因子。在此,我们描述了与IL1RA复合的I型IL1R可溶性细胞外部分分辨率为2.7埃的晶体结构。该受体由三个免疫球蛋白样结构域组成。结构域1和2紧密相连,但结构域3完全分开并通过一个柔性连接子相连。所有三个结构域的残基均与拮抗剂接触,包括通过定点诱变确定的五个关键IL1RA残基。在IL-1β中对生物学功能很重要的一个区域,即“受体触发位点”,在IL1RA复合物中不与受体直接接触。建模研究表明,这个IL-1β触发位点可能会诱导结构域3的移动。

相似文献

1
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.白细胞介素-1受体与拮抗剂的晶体结构揭示了一种新的细胞因子-受体结合模式。
Nature. 1997 Mar 13;386(6621):194-200. doi: 10.1038/386194a0.
2
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.与白细胞介素-1β复合的I型白细胞介素-1受体的晶体结构。
Nature. 1997 Mar 13;386(6621):190-4. doi: 10.1038/386190a0.
3
Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.通过重建白细胞介素-1受体拮抗剂样结构域来绘制白细胞介素-1β上的受体结合位点图谱。
J Immunol. 1995 Nov 15;155(10):4719-25.
4
The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.基于白细胞介素-1受体拮抗剂序列寻找白细胞介素-1抑制剂。
Biomed Pept Proteins Nucleic Acids. 1996;2(4):123-9.
5
Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.鉴定人白细胞介素-11受体中介导配体结合的结构域。
J Mol Biol. 2001 Feb 16;306(2):263-74. doi: 10.1006/jmbi.2000.4387.
6
Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.白细胞介素-1受体拮抗剂的抑制活性取决于其与Ⅰ型白细胞介素-1受体和Ⅱ型白细胞介素-1受体结合能力之间的平衡。
J Immunol. 1997 Apr 15;158(8):3881-7.
7
The structure of interleukin-2 complexed with its alpha receptor.与α受体复合的白细胞介素-2的结构。
Science. 2005 Jun 3;308(5727):1477-80. doi: 10.1126/science.1109745.
8
Modelling of fish interleukin-1 and its receptor.鱼类白细胞介素-1及其受体的建模
Dev Comp Immunol. 2004 May 3;28(5):429-41. doi: 10.1016/j.dci.2003.09.014.
9
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.Toll/白细胞介素-1受体结构域信号转导的结构基础
Nature. 2000 Nov 2;408(6808):111-5. doi: 10.1038/35040600.
10
Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.人白细胞介素-1受体拮抗剂的阴离子结合与可控聚集
Biochemistry. 2005 Jul 26;44(29):9871-9. doi: 10.1021/bi050388g.

引用本文的文献

1
An ancient evolutionary origin for IL-1 cytokines as mediators of immunity.白细胞介素-1细胞因子作为免疫介质具有古老的进化起源。
bioRxiv. 2025 Jul 18:2025.07.17.662885. doi: 10.1101/2025.07.17.662885.
2
Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies.通过编码文库技术发现选择性低分子量白细胞介素-36受体拮抗剂。
Nat Commun. 2025 Feb 15;16(1):1669. doi: 10.1038/s41467-025-56601-7.
3
Unveiling the impact of C15orf48 on non-small cell lung cancer through NF-kappa B signaling.
通过核因子κB信号通路揭示C15orf48对非小细胞肺癌的影响。
Biomol Biomed. 2025 Apr 3;25(5):1162-1174. doi: 10.17305/bb.2024.11113.
4
De novo design of miniprotein antagonists of cytokine storm inducers.从头设计细胞因子风暴诱导剂的小分子蛋白拮抗剂。
Nat Commun. 2024 Aug 16;15(1):7064. doi: 10.1038/s41467-024-50919-4.
5
IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance.免疫细胞中的白细胞介素-1受体动力学:协调免疫精准性与平衡
Immune Netw. 2024 May 29;24(3):e21. doi: 10.4110/in.2024.24.e21. eCollection 2024 Jun.
6
Structure-Based Protein Assembly Simulations Including Various Binding Sites and Conformations.基于结构的蛋白质组装模拟,包括各种结合位点和构象。
J Chem Inf Model. 2024 Apr 22;64(8):3465-3476. doi: 10.1021/acs.jcim.4c00212. Epub 2024 Apr 11.
7
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
8
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β.发现一种选择性的、具有生物活性的人白细胞介素-1β小分子拮抗剂。
Nat Commun. 2023 Sep 7;14(1):5497. doi: 10.1038/s41467-023-41190-0.
9
ANGPTL3 negatively regulates IL-1β-induced NF-κB activation by inhibiting the IL1R1-associated signaling complex assembly.ANGPTL3 通过抑制 IL1R1 相关信号复合物组装来负调控 IL-1β 诱导的 NF-κB 激活。
J Mol Cell Biol. 2024 Jan 17;15(8). doi: 10.1093/jmcb/mjad053.
10
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas.白细胞介素-1受体拮抗剂:一种对抗人类鳞状细胞癌的有前景的细胞因子。
Heliyon. 2023 Mar 28;9(4):e14960. doi: 10.1016/j.heliyon.2023.e14960. eCollection 2023 Apr.